Optimizing the treatment of metastatic castration‑resistant prostate cancer: a Latin America perspective

Dr. Shore, co -author

Prostate cancer is a significant burden and cause of mortality in Latin America. This article reviews the treatment options
for patients with metastatic castration-resistant prostate cancer (mCRPC) and provides consensus recommendations to
assist Latin American prostate cancer specialists with clinical decision making.

click here to read more